NOUGUES MAXIMO F 4

What Happened

• Maximo Nougues, Chief Financial Officer of Puma Biotechnology (PBYI), sold 9,386 shares on 2026-07-06 at $8.26 per share, generating $77,557 in proceeds. This was a sale (not a purchase), executed under a pre-arranged program.

Key Details

• Transaction date and price: 2026-07-06 at $8.26 per share.
• Shares sold: 9,386; Total proceeds: $77,557.
• Method: Reported as an open-market/private sale and noted as part of a 10b5-1(c) sell-to-cover program.
• 10b5-1 plan adoption date (footnote): 12-14-2020.
• Shares owned after transaction: Not specified in the provided Form 4 summary.
• Filing date: Form filed 2026-07-08 for the 2026-07-06 transaction (filed within the typical two-business-day window).

Context

• Sales executed under a 10b5-1 plan are pre-arranged and often routine (e.g., to cover taxes or diversify), so they do not necessarily signal a change in the insider’s view of the company.
• For retail investors, purchases generally carry more informational weight than routine sales; this transaction should be viewed as a routine disposition unless accompanied by other material company news.